Fujifilm invests in JUNTEN BIO, a regenerative medicine venture company Signs a service agreement on the development of regenerative medical products for reducing the use of immunosuppressants
04.06.2019
Tokyo, June 4, 2019 FUJIFILM Corporation (President: Kenji Sukeno) announced that it has entered into an agreement with JUNTEN BIO Co., Ltd. (Junten Bio), a company that targets the practical application of regenerative medical technologies that induce immunotolerance*, to underwrite the company's third-party allocation of shares, and invested a sum of 200 million yen. In making this investment, Fujifilm's subsidiary Japan Tissue Engineering Co. Ltd. (J-TEC) also signed a service agreement with Junten Bio to provide pharmaceutical regulatory consulting service for the development of regenerative medical products.
Through the conclusion of these agreements, Fujifilm will gain access to technologies and knowhow on regenerative medical products that Junten Bio develops, and offer service for supporting pharmaceutical regulatory operations.
Currently, after organ transplants, immunosuppressants are generally used continuously to suppress rejections that occurs as the transplant recipient's immune cells recognize the donor's transplanted organ as foreign. However, continuous administration of immunosuppressants may cause problems such as the increased risk of infections and other complications, and financial burden on the patients.
Junten Bio is a regenerative medicine venture company originating at Juntendo University. It is engaged in developing practical applications of regenerative medical technology developed by Juntendo University, including technologies to combine autologous T-cells** into donor-derived T-cells and antibodies and then culturing the mixture, thereby processing it into autologous T-cells with the ability to induce immunotolerance to donor derived organs. Juntendo University has already performed clinical researches on regenerative medical products that employ this technology, targeting patients who have undergone liver or kidney transplants, and the researches suggest the products' safety as well as efficacy, such as reducing or allowing discontinuation of the use of immunosuppressants.
Fujifilm has been accelerating R&D for in-house regenerative medical products, and expanding our regenerative medicine contract businesses through J-TEC, which became the first in Japan to launch regenerative medical products, and FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading global developer and manufacturer of human induced pluripotent stem (iPS) cell technologies . With this investment, Fujifilm will have access to technologies and know-how relating to regenerative medical products that induce immunotolerance, and will consider applying them to the R&D of in-house regenerative medical products. Moreover, the company will further expand its regenerative medicine contract businesses by having J-TEC offer Junten Bio the supporting services of pharmaceutical regulatory operations on regenerative medical products.
Fujifilm is committed to expanding its business operations and contributing to the promotion of the regenerative medicine business to the industrialization stage by utilizing an array of technologies of Fujifilm group including Fujifilm's high-performance materials and engineering technologies that it has cultivated and enhanced through the development of broad-ranging products, J-TEC's technologies to produce cells for therapeutic use, FCDI's world-leading technologies and know-how relating to iPS cells, and culturing technologies of FUJIFILM Wako Pure Chemical Corporation and FUJIFILM Irvine Scientific, Inc.
* A condition in which specific immune responses against specific antigens are either lacking or being suppressed.
** T-cell is a type of lymphocyte. It possesses T-cell receptors that bind specifically to a certain antigen and, through such receptors, makes immune responses to the antigen. Autologous T-cell is a type of T-cell deriving from the patients themselves.
Overview of Junten Bio Name of company JUNTEN BIO Co., Ltd.
President and Representative Director Masanari Kawaminami
Address 2-1-3 Nihonbashi, Chuo-ku, Tokyo, Japan
Established June 2018
Capital 480 million yen
Line of business Research and development of cell therapy and regenerative medicine products
For inquiries on information in this media release, contact: Media
Most recent headlines
04/08/2024
Dalet, a leading technology and service provider for media-rich organizations, is excited to announce Santiago Solanas as its new Chief Executive Officer (CEO)....
03/06/2024
Dalet, a leading technology and service provider for media-rich organizations, a...
30/04/2024
European telecom satellite company SES announced today that it is acquiring rival Intelsat for $3.1 billion. The deal, unanimously approved by both companies...
30/04/2024
Bob Bakish, chief executive of Paramount stepped down on Monday, effective immediately. Bakish, who was a staunch ally of Shari Redstone, controlling shareholde...
30/04/2024
Hotspring said the breakthrough had been achieved through the acceleration of machine learning technology
By Matthew Corrigan
Published: April 30, 2024
Ho...
30/04/2024
Speaking about the deal, Adel Al-Saleh, CEO of SES, said: it will bring value-added, efficient, and reliable offerings for both companies media customers
By Je...
30/04/2024
Paramount said the Office of the CEO is working with its board to develop a comp...
30/04/2024
LOUISVILLE, Ky. In another sign that broadcasters are finally using NextGen TV broadcasts to offer viewers new features instead of simply simulcasting existing ...
30/04/2024
OKLAHOMA CITY The Oklahoma Journalism Hall of Fame will induct Blaise Labbe, a group news director for Sinclair Broadcast Group, May 2 at the 54th Anniversary I...
30/04/2024
ATLANTA and ENGLEWOOD, Colo. Cox Media Group and Dish have ended a dispute over retransmission fees that lasted nearly a year and a half with a new multi-year ...
30/04/2024
Video transport solution provider LTN has announced that it is working with TelevisaUnivision to help the Spanish-language media giant migrate to IP-based video...
30/04/2024
ALAMEDA, Calif. Clear-Com has released details about how it played a pivotal role in the seamless coverage of the recent solar eclipse on April 8, 2024 by NBC K...
30/04/2024
CINCINNATI The E.W. Scripps Company is adding Seth Walters to its sales leadership team as head of CTV sales, effective April 29....
30/04/2024
The force was strong at the Durham Bulls Athletic Park on Saturday night, April 27, 2024, as the night netted the ballpark's first official sellout crowd of...
30/04/2024
Revry, a network celebrating queer culture. said its second annual NewFront presentation will be a cabaret-type spectacle showcasing the spirit of the LGBTQ+ co...
30/04/2024
Family Entertainment Television (FETV) said that the Western series The Life and Legend of Wyatt Earp will be joining the network's afternoon lineup startin...
30/04/2024
Bob Bakish, president and CEO of Paramount Global, will depart the company as Paramount explores a merger, according to numerous published reports. The reports ...
30/04/2024
Value accretive transaction underpinned by 2.4 billion (NPV) of readily executable synergies.
Creating a stronger multi-orbit operator with 60% of revenue in...
30/04/2024
Facebook
Twitter
LinkedIn
Order intake: 5.0 billion, up 47% ( 46% on an organic basis1 )
Sales: 4.4 billion, up 9.8% ( 7.9% on an organic basis)
All f...
29/04/2024
(L-R) Mark Gatiss and Polly Walker on set
Monday 29 April 2024 Further casting is now confirmed for Bookish (6x70), a brand-new drama created by Emmy Award-wi...
29/04/2024
A groundbreaking initiative offering training and mentoring to 30 women journali...
29/04/2024
Even though we've been doing this for over 40 years, a spark of excitement r...
29/04/2024
L3Harris is delivering manpack radios to U.S. Army CH-47 Chinooks as part of the Air-to-Ground Networking Radio program, providing seamless, resilient communica...
29/04/2024
He writes in Defense One: Despite the near-universal acknowledgement throughout the U.S. government and defense industrial base of the criticality of resilient ...
29/04/2024
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
29/04/2024
Codemill aims to revolutionize media workflow efficiency at this years NAB Show by introducing Just-In-Time (JIT) playback technology in Accurate.Video Validate...
29/04/2024
April 29, 2024
-- TF1 Chooses Broadpeak to Power Targeted Advertising for New...
29/04/2024
LOS ANGELES Allen Media Group (AMG) has partnered with LG Electronics to bring 223 Local Now FAST channels to LG's free streaming service, LG Channels, avai...
29/04/2024
OTTAWA Ross Video has announced the introduction of Raiden, a data-driven weather graphics software that combines data gathering, processing, and visualization ...
29/04/2024
Panalux, a leading rental provider of lighting and power solutions for the motion-picture industry and part of Panavision's end-to-end service offerings for...
29/04/2024
Cobalt Iron Inc., a leading provider of SaaS-based enterprise data protection, today announced that it has received a patent on its technology for dynamic autho...
29/04/2024
SDVI, the leading platform provider for cloud-native media supply chains, today announced that Rally Access Workstation, a fully managed solution for editing in...
29/04/2024
Premier Sports, a premium sports broadcaster, has selected QuickLink's Remote Commentary solution for introducing professional, high-quality remote commenta...
29/04/2024
Glookast has chosen Jigsaw24 Media as the only UK channel partner to represent their portfolio of ingest and workflow optimisation products. The agreement, sign...
29/04/2024
Clear-Com played a pivotal role in the seamless coverage of the recent solar eclipse on April 8, 2024. Leveraging its cutting-edge Eclipse HX Digital Matrix i...
29/04/2024
PlayBox Neo will promote its complete range of television channel management, graphic branding and playout solutions to EMEA region media content owners and bro...
29/04/2024
Lingo, RuPaul's word-twisting game show, returns for season two on CBS Friday, May 24. Two episodes air that night, and stream on Paramount Plus, too....
29/04/2024
ESPN and Amazon Prime Video are reportedly close to scoring television rights to the National Basketball Association, according to published reports....
29/04/2024
Judge Judy and Hot Bench, CBS Media Ventures' genre-leading court shows, have been renewed through the 2025-26 TV season in more than 95% of the country, Gr...
29/04/2024
Premier Sports, an Irish-based premium sports broadcaster, has selected QuickLink's Remote Commentary solution for introducing professional, high-quality re...
29/04/2024
The awards celebrate the craft of behind-the-scenes TV talent and the best programmes of 2023
By Matthew Corrigan
Published: April 29, 2024
The awards cel...
29/04/2024
The team at Milk had to create and deliver the VFX and environment work for the royal residences featured in the drama from scratch
By Jenny Priestley
Publis...
29/04/2024
CEO Bob Bakish is expected to leave the company as early as today, with a new leadership committee likely to run the company on an interim basis
By Jenny Pries...
29/04/2024
Albena Ivanova, director, media and entertainment and strategic products at CHAOS talks to TVBEurope about her route into the industry
By TVBEurope Staff
Pub...
29/04/2024
The acquisition gives Grand Technix the opportunity to expand its footprint in the audio visual and broadcast technology sectors
By Jenny Priestley
Published...
29/04/2024
29 04 2024 - Media release Screen Australia announces James J. Robinson's debut feature First Light
First Light
Principal Photography is underway on Firs...
29/04/2024
Capitol Broadcasting recently became the inaugural company honored with inductio...
29/04/2024
Tonight on House of Zwide: Zanele tells a surprised Zola that Faith fully suppor...
29/04/2024
Tonight on Scandal: A line is crossed and a mother starts to lose focusDon't miss Friday, 26 April's riveting episode of South African soapie Scandal! o...
Fujifilm invests in JUNTEN BIO, a regenerative medicine venture company Signs a service agreement on the development of regenerative medical products for reducing the use of immunosuppressants
